A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction Therapy

Condition:   Gaucher Disease Intervention:   Drug: Velaglucerase alfa Sponsor:   Takeda Not yet recruiting

Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials